Kevin Charles Gorman
Director at Neurocrine Biosciences Inc (NBIX); Director at Xencor Inc (XNCR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $37.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 17SEC | XNCRXencor Inc | Sell Plan | 7,52711,378 held (−40%) | $12.31 | $93K | +85.6% |
| May 21SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 245,088511,293 held (−32%) | $154.33 | $37.8M | -12.1% |
- Sell
Director Kevin Charles Gorman sold $93K of XNCR at $12.31 — cuts the stake by 40%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Kevin Charles Gorman sold $37.8M of NBIX at $154.33 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.